speb/financial-data huggingface dataset:
PCVX cash_flow (annual, 2022-12-31) — Investing Cash Flow: 74585000.00
PCVX balance_sheet (annual, 2022-12-31) — Investments And Advances: 26549000.00
PCVX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 856480000.00
PCVX balance_sheet (annual, 2022-12-31) — Leases: 1353000.00
PCVX balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 12031000.00
PCVX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 12031000.00
PCVX cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
PCVX balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 2024000.00
PCVX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 856480000.00
PCVX cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
PCVX income_statement (annual, 2022-12-31) — Net Income: -223485000.00
PCVX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -223485000.00
PCVX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -223485000.00
PCVX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -223485000.00
PCVX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -223485000.00
PCVX cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -223485000.00
PCVX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -223485000.00
PCVX income_statement (annual, 2022-12-31) — Net Interest Income: 8354000.00
PCVX cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 80426000.00
PCVX cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
PCVX cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
PCVX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 8354000.00
PCVX cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -861000.00
PCVX balance_sheet (annual, 2022-12-31) — Net PPE: 31648000.00
PCVX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -5841000.00
PCVX cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
PCVX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 953613000.00
PCVX balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 4361000.00
PCVX income_statement (annual, 2022-12-31) — Normalized EBITDA: -191035000.00
PCVX income_statement (annual, 2022-12-31) — Normalized Income: -200490000.00
PCVX cash_flow (annual, 2022-12-31) — Operating Cash Flow: -170597000.00
PCVX cash_flow (annual, 2022-12-31) — Operating Gains Losses: 44000.00
PCVX income_statement (annual, 2022-12-31) — Operating Income: -209261000.00
PCVX income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
PCVX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 79470670.00
PCVX balance_sheet (annual, 2022-12-31) — Other Current Assets: 11179000.00
PCVX balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -361000.00
PCVX income_statement (annual, 2022-12-31) — Other Gand A: 39810000.00
PCVX income_statement (annual, 2022-12-31) — Other Income Expense: -22578000.00
PCVX cash_flow (annual, 2022-12-31) — Other Non Cash Items: 7048000.00
PCVX balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1065000.00
PCVX balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 9000.00
PCVX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 417000.00
PCVX income_statement (annual, 2022-12-31) — Other Operating Expenses: -1931000.00
PCVX balance_sheet (annual, 2022-12-31) — Other Properties: 34388000.00
PCVX balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 96719000.00
PCVX balance_sheet (annual, 2022-12-31) — Payables: 9795000.00
PCVX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 33435000.00
PCVX balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1180000.00
PCVX balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
PCVX cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
PCVX balance_sheet (annual, 2022-12-31) — Prepaid Assets: 11179000.00
PCVX income_statement (annual, 2022-12-31) — Pretax Income: -223485000.00
PCVX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 5928000.00
PCVX balance_sheet (annual, 2022-12-31) — Properties: 0.00
PCVX cash_flow (annual, 2022-12-31) — Purchase Of Investment: -102745000.00
PCVX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -5841000.00
PCVX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 9453000.00
PCVX cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
PCVX income_statement (annual, 2022-12-31) — Research And Development: 169451000.00
PCVX income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 22995000.00
PCVX balance_sheet (annual, 2022-12-31) — Retained Earnings: -522126000.00
PCVX cash_flow (annual, 2022-12-31) — Sale Of Investment: 183171000.00
PCVX cash_flow (annual, 2022-12-31) — Sale Of PPE: 7000.00
PCVX income_statement (annual, 2022-12-31) — Selling General And Administration: 39810000.00
PCVX balance_sheet (annual, 2022-12-31) — Share Issued: 79470670.00
PCVX income_statement (annual, 2022-12-31) — Special Income Charges: -22995000.00
PCVX cash_flow (annual, 2022-12-31) — Stock Based Compensation: 23650000.00
PCVX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 953613000.00
PCVX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 953613000.00
PCVX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
PCVX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
PCVX balance_sheet (annual, 2022-12-31) — Total Assets: 1006178000.00
PCVX balance_sheet (annual, 2022-12-31) — Total Capitalization: 953613000.00
PCVX balance_sheet (annual, 2022-12-31) — Total Debt: 17941000.00
PCVX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 953613000.00
PCVX income_statement (annual, 2022-12-31) — Total Expenses: 209261000.00
PCVX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 52565000.00
PCVX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 63623000.00
PCVX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 12040000.00
PCVX income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -232256000.00
PCVX income_statement (annual, 2022-12-31) — Total Unusual Items: -22995000.00
PCVX income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -22995000.00
PCVX balance_sheet (annual, 2022-12-31) — Working Capital: 902030000.00
PCVX income_statement (annual, 2023-12-31) — +Operating Expense: 393041000.00
PCVX income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
PCVX balance_sheet (annual, 2023-12-31) — Accounts Payable: 14587000.00
PCVX balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -9272000.00
PCVX balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 2164583000.00
PCVX cash_flow (annual, 2023-12-31) — Amortization Of Securities: -34775000.00
PCVX cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
PCVX balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 162675000.00
PCVX income_statement (annual, 2023-12-31) — Basic Average Shares: 97157690.00
PCVX income_statement (annual, 2023-12-31) — Basic EPS: -4.14
PCVX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 835528000.00
PCVX cash_flow (annual, 2023-12-31) — Capital Expenditure: -67877000.00
PCVX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 29224000.00
PCVX balance_sheet (annual, 2023-12-31) — Capital Stock: 98000.00
PCVX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 397451000.00
PCVX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 1080227000.00
PCVX balance_sheet (annual, 2023-12-31) — Cash Equivalents: 347448000.00
PCVX balance_sheet (annual, 2023-12-31) — Cash Financial: 50003000.00
PCVX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 639813000.00
PCVX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -773311000.00
PCVX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -296790000.00
PCVX cash_flow (annual, 2023-12-31) — Change In Account Payable: 11225000.00
PCVX cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 80796000.00
PCVX cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -49731000.00
PCVX cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 11284000.00
PCVX cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 9876000.00
PCVX cash_flow (annual, 2023-12-31) — Change In Payable: 11225000.00
PCVX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 92021000.00
PCVX cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 17870000.00
PCVX cash_flow (annual, 2023-12-31) — Change In Working Capital: 81320000.00
PCVX cash_flow (annual, 2023-12-31) — Changes In Cash: -430288000.00
PCVX balance_sheet (annual, 2023-12-31) — Common Stock: 98000.00
PCVX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1240468000.00
PCVX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 636043000.00
PCVX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 112582000.00
PCVX balance_sheet (annual, 2023-12-31) — Current Assets: 1095954000.00
PCVX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 7113000.00
PCVX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 7113000.00
PCVX balance_sheet (annual, 2023-12-31) — Current Liabilities: 145338000.00
PCVX cash_flow (annual, 2023-12-31) — Depreciation: 10171000.00
PCVX cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 10171000.00
PCVX cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 10171000.00
PCVX income_statement (annual, 2023-12-31) — Diluted Average Shares: 97157690.00
PCVX income_statement (annual, 2023-12-31) — Diluted EPS: -4.14
PCVX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -402266000.00
PCVX income_statement (annual, 2023-12-31) — EBIT: -393041000.00
PCVX income_statement (annual, 2023-12-31) — EBITDA: -382870000.00
PCVX cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -6686000.00
PCVX cash_flow (annual, 2023-12-31) — End Cash Position: 398554000.00
PCVX cash_flow (annual, 2023-12-31) — Financing Cash Flow: 639813000.00
PCVX cash_flow (annual, 2023-12-31) — Free Cash Flow: -364667000.00
PCVX income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 0.00
PCVX income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -1897000.00
PCVX balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 179000.00
PCVX income_statement (annual, 2023-12-31) — General And Administrative Expense: 60700000.00
PCVX balance_sheet (annual, 2023-12-31) — Gross PPE: 154583000.00
PCVX income_statement (annual, 2023-12-31) — Interest Expense: 0.00
PCVX income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 0.00
PCVX income_statement (annual, 2023-12-31) — Interest Income: 62907000.00
PCVX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 62907000.00
PCVX cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 0.00
PCVX balance_sheet (annual, 2023-12-31) — Invested Capital: 1240468000.00
PCVX cash_flow (annual, 2023-12-31) — Investing Cash Flow: -773311000.00
PCVX balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 162675000.00
PCVX balance_sheet (annual, 2023-12-31) — Investments And Advances: 162675000.00
PCVX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 636043000.00
PCVX balance_sheet (annual, 2023-12-31) — Leases: 1460000.00
PCVX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 22111000.00
PCVX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 22111000.00
PCVX balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 88882000.00
PCVX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 636043000.00
PCVX cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
PCVX income_statement (annual, 2023-12-31) — Net Income: -402266000.00
PCVX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -402266000.00
PCVX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -402266000.00
PCVX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -402266000.00
PCVX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -402266000.00
PCVX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -402266000.00
PCVX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -402266000.00
PCVX income_statement (annual, 2023-12-31) — Net Interest Income: 62907000.00
PCVX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -705434000.00
PCVX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 62907000.00
PCVX cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -3876000.00
PCVX balance_sheet (annual, 2023-12-31) — Net PPE: 145311000.00
PCVX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -67877000.00
PCVX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 1240468000.00
PCVX balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 2768000.00
PCVX income_statement (annual, 2023-12-31) — Normalized EBITDA: -307870000.00
PCVX income_statement (annual, 2023-12-31) — Normalized Income: -327266000.00
PCVX cash_flow (annual, 2023-12-31) — Operating Cash Flow: -296790000.00
PCVX income_statement (annual, 2023-12-31) — Operating Income: -393041000.00
PCVX income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
PCVX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 95364831.00
PCVX balance_sheet (annual, 2023-12-31) — Other Current Assets: 15727000.00
PCVX balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 179000.00
PCVX income_statement (annual, 2023-12-31) — Other Gand A: 60700000.00
PCVX income_statement (annual, 2023-12-31) — Other Income Expense: -72132000.00
PCVX cash_flow (annual, 2023-12-31) — Other Non Cash Items: -34775000.00
PCVX balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 3977000.00
PCVX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 2868000.00
PCVX income_statement (annual, 2023-12-31) — Other Operating Expenses: -4765000.00
PCVX balance_sheet (annual, 2023-12-31) — Other Properties: 64241000.00
PCVX balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 682776000.00
PCVX balance_sheet (annual, 2023-12-31) — Payables: 14587000.00
PCVX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 127169000.00
PCVX balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 11056000.00
PCVX balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
PCVX income_statement (annual, 2023-12-31) — Pretax Income: -402266000.00
PCVX cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 7646000.00
PCVX balance_sheet (annual, 2023-12-31) — Properties: 0.00
PCVX cash_flow (annual, 2023-12-31) — Purchase Of Investment: -1329896000.00
PCVX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -67877000.00
PCVX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 10171000.00
PCVX income_statement (annual, 2023-12-31) — Research And Development: 332341000.00
PCVX income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 75000000.00
PCVX balance_sheet (annual, 2023-12-31) — Retained Earnings: -924392000.00
PCVX cash_flow (annual, 2023-12-31) — Sale Of Investment: 624462000.00
PCVX cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
PCVX income_statement (annual, 2023-12-31) — Selling General And Administration: 60700000.00
PCVX balance_sheet (annual, 2023-12-31) — Share Issued: 95364831.00
PCVX income_statement (annual, 2023-12-31) — Special Income Charges: -75000000.00
PCVX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 48760000.00
PCVX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1240468000.00
PCVX balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1240468000.00
PCVX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
PCVX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
PCVX balance_sheet (annual, 2023-12-31) — Total Assets: 1407917000.00
PCVX balance_sheet (annual, 2023-12-31) — Total Capitalization: 1240468000.00
PCVX balance_sheet (annual, 2023-12-31) — Total Debt: 29224000.00
PCVX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1240468000.00
PCVX income_statement (annual, 2023-12-31) — Total Expenses: 393041000.00
PCVX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 167449000.00
PCVX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 311963000.00
PCVX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 22111000.00
PCVX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -468041000.00
PCVX income_statement (annual, 2023-12-31) — Total Unusual Items: -75000000.00
PCVX income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -75000000.00
PCVX balance_sheet (annual, 2023-12-31) — Working Capital: 950616000.00
PCVX balance_sheet (quarterly, 2024-09-30) — Accrued Interest Receivable: 17574000.00
PCVX balance_sheet (quarterly, 2024-09-30) — Accumulated Depreciation: -13411000.00
PCVX income_statement (quarterly, 2024-09-30) — Basic Average Shares: 123693461.00
PCVX income_statement (quarterly, 2024-09-30) — Basic EPS: -0.83
PCVX income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 123693461.00
PCVX income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.83
PCVX income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: 8451000.00
PCVX balance_sheet (quarterly, 2024-09-30) — Leases: 4059000.00
PCVX balance_sheet (quarterly, 2024-09-30) — Machinery Furniture Equipment: 183868000.00
PCVX balance_sheet (quarterly, 2024-09-30) — Non Current Prepaid Assets: 284000.00
PCVX income_statement (quarterly, 2024-09-30) — Other Operating Expenses: -292000.00
PCVX balance_sheet (quarterly, 2024-09-30) — Other Receivables: 298000.00
PCVX balance_sheet (quarterly, 2024-09-30) — Prepaid Assets: 12085000.00
PCVX balance_sheet (quarterly, 2024-09-30) — Properties: 0.00
PCVX balance_sheet (quarterly, 2024-09-30) — Receivables: 17872000.00
PCVX income_statement (quarterly, 2024-09-30) — Total Unusual Items: 8451000.00
PCVX income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 8451000.00
PCVX income_statement (annual, 2024-12-31) — +Operating Expense: 569546000.00
PCVX income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
PCVX balance_sheet (annual, 2024-12-31) — Accounts Payable: 48452000.00
PCVX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -16274000.00
PCVX balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -16274000.00
PCVX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 4697883000.00
PCVX balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 1387510000.00
PCVX balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 1387510000.00
PCVX income_statement (annual, 2024-12-31) — Basic Average Shares: 121997348.00
PCVX income_statement (annual, 2024-12-31) — Basic EPS: -3.80
PCVX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 398554000.00
PCVX cash_flow (annual, 2024-12-31) — Capital Expenditure: -119159000.00
PCVX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 71110000.00
PCVX balance_sheet (annual, 2024-12-31) — Capital Stock: 128000.00
PCVX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 387878000.00
PCVX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1747208000.00
PCVX balance_sheet (annual, 2024-12-31) — Cash Equivalents: 327347000.00
PCVX balance_sheet (annual, 2024-12-31) — Cash Financial: 60531000.00
PCVX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 2448508000.00
PCVX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -2005666000.00
PCVX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -452627000.00
PCVX cash_flow (annual, 2024-12-31) — Change In Account Payable: 34584000.00
PCVX cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -58596000.00
PCVX cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -76459000.00
PCVX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 41886000.00
PCVX cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 9517000.00
PCVX cash_flow (annual, 2024-12-31) — Change In Payable: 34584000.00
PCVX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -24012000.00
PCVX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -5827000.00
PCVX cash_flow (annual, 2024-12-31) — Change In Working Capital: -54895000.00
PCVX cash_flow (annual, 2024-12-31) — Changes In Cash: -9785000.00
PCVX balance_sheet (annual, 2024-12-31) — Common Stock: 128000.00
PCVX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 3305819000.00
PCVX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 2435656000.00
PCVX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 65180000.00
PCVX balance_sheet (annual, 2024-12-31) — Current Assets: 1787985000.00
PCVX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 5891000.00
PCVX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 5891000.00
PCVX balance_sheet (annual, 2024-12-31) — Current Liabilities: 140180000.00
PCVX cash_flow (annual, 2024-12-31) — Depreciation: 15845000.00
PCVX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 15845000.00
PCVX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 15845000.00
PCVX income_statement (annual, 2024-12-31) — Diluted Average Shares: 121997348.00
PCVX income_statement (annual, 2024-12-31) — Diluted EPS: -3.80
PCVX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -463927000.00
PCVX income_statement (annual, 2024-12-31) — EBIT: -569546000.00
PCVX income_statement (annual, 2024-12-31) — EBITDA: -553701000.00
PCVX cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 426000.00
PCVX cash_flow (annual, 2024-12-31) — End Cash Position: 389195000.00
PCVX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 2448508000.00
PCVX cash_flow (annual, 2024-12-31) — Free Cash Flow: -571786000.00
PCVX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -3873000.00
PCVX income_statement (annual, 2024-12-31) — General And Administrative Expense: 92902000.00
PCVX balance_sheet (annual, 2024-12-31) — Gross PPE: 348898000.00
PCVX income_statement (annual, 2024-12-31) — Interest Expense: 0.00
PCVX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 0.00
PCVX income_statement (annual, 2024-12-31) — Interest Income: 109994000.00
PCVX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 109994000.00
PCVX balance_sheet (annual, 2024-12-31) — Invested Capital: 3305819000.00
PCVX cash_flow (annual, 2024-12-31) — Investing Cash Flow: -2005666000.00
PCVX balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 1387510000.00
PCVX balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 1387510000.00
PCVX balance_sheet (annual, 2024-12-31) — Investments And Advances: 1387510000.00
PCVX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 2435656000.00
PCVX balance_sheet (annual, 2024-12-31) — Leases: 4384000.00
PCVX balance_sheet (quarterly, 2024-12-31) — Leases: 4384000.00
PCVX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 65219000.00
PCVX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 65219000.00
PCVX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 216871000.00
PCVX balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 216871000.00
PCVX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 2435656000.00
PCVX cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 4232000.00
PCVX income_statement (annual, 2024-12-31) — Net Income: -463927000.00
PCVX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -463927000.00
PCVX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -463927000.00
PCVX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -463927000.00
PCVX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -463927000.00
PCVX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -463927000.00
PCVX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -463927000.00
PCVX income_statement (annual, 2024-12-31) — Net Interest Income: 109994000.00
PCVX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -1886507000.00
PCVX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 109994000.00
PCVX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -14292000.00
PCVX balance_sheet (annual, 2024-12-31) — Net PPE: 332624000.00
PCVX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -119159000.00
PCVX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 3305819000.00
PCVX income_statement (annual, 2024-12-31) — Normalized EBITDA: -553701000.00
PCVX income_statement (annual, 2024-12-31) — Normalized Income: -463927000.00
PCVX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -452627000.00
PCVX cash_flow (annual, 2024-12-31) — Operating Gains Losses: 4232000.00
PCVX income_statement (annual, 2024-12-31) — Operating Income: -569546000.00
PCVX income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
PCVX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 124893034.00
PCVX balance_sheet (annual, 2024-12-31) — Other Current Assets: 40777000.00
PCVX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -3873000.00
PCVX income_statement (annual, 2024-12-31) — Other Gand A: 92902000.00
PCVX income_statement (annual, 2024-12-31) — Other Income Expense: -4375000.00
PCVX cash_flow (annual, 2024-12-31) — Other Non Cash Items: -38704000.00
PCVX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 3199000.00
PCVX balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 100000.00
PCVX balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 100000.00
PCVX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -4375000.00
PCVX balance_sheet (annual, 2024-12-31) — Other Properties: 127643000.00
PCVX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 1359330000.00
PCVX balance_sheet (annual, 2024-12-31) — Payables: 48554000.00
PCVX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 113734000.00
PCVX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 20555000.00
PCVX balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
PCVX income_statement (annual, 2024-12-31) — Pretax Income: -463927000.00
PCVX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 27144000.00
PCVX balance_sheet (annual, 2024-12-31) — Properties: 0.00
PCVX balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
PCVX cash_flow (annual, 2024-12-31) — Purchase Of Investment: -3086701000.00
PCVX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -119159000.00
PCVX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 15845000.00
PCVX income_statement (annual, 2024-12-31) — Research And Development: 476644000.00
PCVX income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
PCVX balance_sheet (annual, 2024-12-31) — Retained Earnings: -1388319000.00
PCVX cash_flow (annual, 2024-12-31) — Sale Of Investment: 1200194000.00
PCVX income_statement (annual, 2024-12-31) — Selling General And Administration: 92902000.00
PCVX balance_sheet (annual, 2024-12-31) — Share Issued: 124893034.00
PCVX income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
PCVX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 84822000.00
PCVX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 3305819000.00
PCVX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 3305819000.00
PCVX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
PCVX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
PCVX balance_sheet (annual, 2024-12-31) — Total Assets: 3511318000.00
PCVX balance_sheet (annual, 2024-12-31) — Total Capitalization: 3305819000.00
PCVX balance_sheet (annual, 2024-12-31) — Total Debt: 71110000.00
PCVX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 3305819000.00
PCVX income_statement (annual, 2024-12-31) — Total Expenses: 569546000.00
PCVX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 205499000.00
PCVX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1723333000.00
PCVX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 65319000.00
PCVX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -569546000.00
PCVX balance_sheet (annual, 2024-12-31) — Total Tax Payable: 102000.00
PCVX balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 102000.00
PCVX income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
PCVX income_statement (quarterly, 2024-12-31) — Total Unusual Items: -6182000.00
PCVX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
PCVX income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -6182000.00
PCVX balance_sheet (annual, 2024-12-31) — Working Capital: 1647805000.00
PCVX income_statement (quarterly, 2025-03-31) — +Operating Expense: 180793000.00
PCVX income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
PCVX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 20514000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 4729253000.00
PCVX cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -4913000.00
PCVX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 135690949.00
PCVX income_statement (quarterly, 2025-03-31) — Basic EPS: -1.04
PCVX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 389195000.00
PCVX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -26751000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 87209000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 132000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 346850000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1671731000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 281470000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Cash Financial: 65380000.00
PCVX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 759000.00
PCVX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 123317000.00
PCVX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -166274000.00
PCVX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -29163000.00
PCVX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 3695000.00
PCVX cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -24129000.00
PCVX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 15999000.00
PCVX cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -14418000.00
PCVX cash_flow (quarterly, 2025-03-31) — Change In Payable: -29163000.00
PCVX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -25468000.00
PCVX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -1499000.00
PCVX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -49515000.00
PCVX cash_flow (quarterly, 2025-03-31) — Changes In Cash: -42198000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Common Stock: 132000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 3200026000.00
PCVX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
PCVX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 64365000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Current Assets: 1716563000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 6128000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 6128000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 96996000.00
PCVX cash_flow (quarterly, 2025-03-31) — Depreciation: 4874000.00
PCVX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 4874000.00
PCVX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 4874000.00
PCVX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 135690949.00
PCVX income_statement (quarterly, 2025-03-31) — Diluted EPS: -1.04
PCVX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -140718000.00
PCVX income_statement (quarterly, 2025-03-31) — EBIT: -180793000.00
PCVX income_statement (quarterly, 2025-03-31) — EBITDA: -175919000.00
PCVX cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 1172000.00
PCVX cash_flow (quarterly, 2025-03-31) — End Cash Position: 348169000.00
PCVX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 759000.00
PCVX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -193025000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -322000.00
PCVX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 32659000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 304914000.00
PCVX income_statement (quarterly, 2025-03-31) — Interest Income: 32935000.00
PCVX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 32935000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 3200026000.00
PCVX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 123317000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 1279031000.00
PCVX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
PCVX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 81081000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 81081000.00
PCVX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
PCVX cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -6617000.00
PCVX income_statement (quarterly, 2025-03-31) — Net Income: -140718000.00
PCVX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -140718000.00
PCVX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -140718000.00
PCVX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -140718000.00
PCVX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -140718000.00
PCVX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -140718000.00
PCVX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -140718000.00
PCVX income_statement (quarterly, 2025-03-31) — Net Interest Income: 32935000.00
PCVX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 150068000.00
PCVX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 32935000.00
PCVX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -5290000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Net PPE: 304914000.00
PCVX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -26751000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 3200026000.00
PCVX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -175919000.00
PCVX income_statement (quarterly, 2025-03-31) — Normalized Income: -140718000.00
PCVX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -166274000.00
PCVX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -6617000.00
PCVX income_statement (quarterly, 2025-03-31) — Operating Income: -180793000.00
PCVX income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
PCVX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 128939412.00
PCVX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 44832000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -322000.00
PCVX income_statement (quarterly, 2025-03-31) — Other Gand A: 32659000.00
PCVX income_statement (quarterly, 2025-03-31) — Other Income Expense: 7140000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 77595000.00
PCVX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 7140000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Other Properties: 304914000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1324881000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Payables: 20514000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 84879000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 5989000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
PCVX income_statement (quarterly, 2025-03-31) — Pretax Income: -140718000.00
PCVX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 6049000.00
PCVX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -314485000.00
PCVX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -26751000.00
PCVX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 4874000.00
PCVX income_statement (quarterly, 2025-03-31) — Research And Development: 148134000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1529037000.00
PCVX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 464553000.00
PCVX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 32659000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Share Issued: 128939412.00
PCVX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 30615000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3200026000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 3200026000.00
PCVX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
PCVX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
PCVX balance_sheet (quarterly, 2025-03-31) — Total Assets: 3378103000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 3200026000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Total Debt: 87209000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3200026000.00
PCVX income_statement (quarterly, 2025-03-31) — Total Expenses: 180793000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 178077000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1661540000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 81081000.00
PCVX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -180793000.00
PCVX balance_sheet (quarterly, 2025-03-31) — Working Capital: 1619567000.00
PCVX income_statement (quarterly, 2025-06-30) — +Operating Expense: 226219000.00
PCVX income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
PCVX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 31414000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 4768698000.00
PCVX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 136033746.00
PCVX income_statement (quarterly, 2025-06-30) — Basic EPS: -1.22
PCVX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 348169000.00
PCVX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -9755000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 85845000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 133000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 306744000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1661427000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 254249000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Cash Financial: 52495000.00
PCVX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 2518000.00
PCVX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 77742000.00
PCVX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -121166000.00
PCVX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 9525000.00
PCVX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 38128000.00
PCVX cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -10477000.00
PCVX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -1364000.00
PCVX cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 4546000.00
PCVX cash_flow (quarterly, 2025-06-30) — Change In Payable: 9525000.00
PCVX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 47653000.00
PCVX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -6667000.00
PCVX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 33691000.00
PCVX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -40906000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Common Stock: 133000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3071334000.00
PCVX cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
PCVX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 105940000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Current Assets: 1715775000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 6302000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 6302000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 154486000.00
PCVX cash_flow (quarterly, 2025-06-30) — Depreciation: 4989000.00
PCVX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 4989000.00
PCVX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 4989000.00
PCVX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 136033746.00
PCVX income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.22
PCVX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -166573000.00
PCVX income_statement (quarterly, 2025-06-30) — EBIT: -226219000.00
PCVX income_statement (quarterly, 2025-06-30) — EBITDA: -221230000.00
PCVX cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 800000.00
PCVX cash_flow (quarterly, 2025-06-30) — End Cash Position: 308063000.00
PCVX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 2518000.00
PCVX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -130921000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -1887000.00
PCVX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 32040000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 327915000.00
PCVX income_statement (quarterly, 2025-06-30) — Interest Income: 31073000.00
PCVX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 31073000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 3071334000.00
PCVX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 77742000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 1165091000.00
PCVX cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
PCVX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 79543000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 79543000.00
PCVX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
PCVX cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -25707000.00
PCVX income_statement (quarterly, 2025-06-30) — Net Income: -166573000.00
PCVX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -166573000.00
PCVX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -166573000.00
PCVX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -166573000.00
PCVX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -166573000.00
PCVX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -166573000.00
PCVX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -166573000.00
PCVX income_statement (quarterly, 2025-06-30) — Net Interest Income: 31073000.00
PCVX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 87497000.00
PCVX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 31073000.00
PCVX cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -717000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Net PPE: 327915000.00
PCVX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -9755000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 3071334000.00
PCVX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -221230000.00
PCVX income_statement (quarterly, 2025-06-30) — Normalized Income: -166573000.00
PCVX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -121166000.00
PCVX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -25707000.00
PCVX income_statement (quarterly, 2025-06-30) — Operating Income: -226219000.00
PCVX income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
PCVX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 129816472.00
PCVX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 54348000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -1887000.00
PCVX income_statement (quarterly, 2025-06-30) — Other Gand A: 32040000.00
PCVX income_statement (quarterly, 2025-06-30) — Other Income Expense: 28573000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 96582000.00
PCVX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 28573000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Other Properties: 327915000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 1354683000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Payables: 31414000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 137354000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 10830000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
PCVX income_statement (quarterly, 2025-06-30) — Pretax Income: -166573000.00
PCVX cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 3235000.00
PCVX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -349050000.00
PCVX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -9755000.00
PCVX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 4989000.00
PCVX income_statement (quarterly, 2025-06-30) — Research And Development: 194179000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1695610000.00
PCVX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 436547000.00
PCVX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 32040000.00
PCVX balance_sheet (quarterly, 2025-06-30) — Share Issued: 129816472.00